HEXARELIN

Growth Hormone SecretionResearch Only

Solid research foundation with human studies backing its reputation as the most potent GHRP. Evidence quality is respectable for the peptide research field, though long-term safety data remains limited.

Exercise physiologists and endocrinology researchers studying growth hormone dynamics, particularly when they need reliable, measurable GH spikes for their experimental protocols.

FDA Status

Research Only

Since Feb 2026

Evidence

Moderate

Studies

30 total, 10 human

What is HEXARELIN?

Among growth hormone-releasing peptides, this synthetic compound stands out for delivering unusually powerful GH responses that don't fade with repeated use. Researchers gravitate toward hexarelin when they need maximum growth hormone stimulation in their studies. It's become a benchmark for comparing other GHRPs due to its consistent potency across different research populations.

Hexarelin binds to ghrelin receptors (also called growth hormone secretagogue receptors) in the pituitary gland and hypothalamus, triggering a cascade that releases stored growth hormone. Unlike many peptides that lose effectiveness over time, it maintains its punch even with daily administration, likely because it activates multiple receptor subtypes simultaneously.

What the Research Shows

With 30 studies including 10 human trials, the evidence base is more robust than most research peptides, though many studies focus on short-term hormone responses rather than clinical outcomes.